Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-23-302158
Filing Date
2023-12-22
Accepted
2023-12-22 16:32:10
Documents
165

Document Format Files

Seq Description Document Type Size
1 S-1 d518298ds1.htm   iXBRL S-1 3472611
2 EX-2.1 d518298dex21.htm EX-2.1 727680
3 EX-3.1 d518298dex31.htm EX-3.1 30401
4 EX-3.2 d518298dex32.htm EX-3.2 111897
5 EX-3.3 d518298dex33.htm EX-3.3 79638
6 EX-3.4 d518298dex34.htm EX-3.4 77119
7 EX-4.1 d518298dex41.htm EX-4.1 137213
8 EX-4.2 d518298dex42.htm EX-4.2 3561
9 EX-4.3 d518298dex43.htm EX-4.3 309416
10 EX-4.4 d518298dex44.htm EX-4.4 170178
11 EX-4.5 d518298dex45.htm EX-4.5 58242
12 EX-5.1 d518298dex51.htm EX-5.1 7250
13 EX-10.1 d518298dex101.htm EX-10.1 160577
14 EX-10.2 d518298dex102.htm EX-10.2 77952
15 EX-10.3 d518298dex103.htm EX-10.3 13747
16 EX-10.4 d518298dex104.htm EX-10.4 65356
17 EX-10.5 d518298dex105.htm EX-10.5 126670
18 EX-10.6 d518298dex106.htm EX-10.6 53875
19 EX-10.7 d518298dex107.htm EX-10.7 325760
20 EX-10.8 d518298dex108.htm EX-10.8 118679
21 EX-10.9 d518298dex109.htm EX-10.9 61495
22 EX-10.10 d518298dex1010.htm EX-10.10 103635
23 EX-10.11 d518298dex1011.htm EX-10.11 37964
24 EX-10.12 d518298dex1012.htm EX-10.12 68452
25 EX-10.13 d518298dex1013.htm EX-10.13 62105
26 EX-10.14 d518298dex1014.htm EX-10.14 52844
27 EX-10.15 d518298dex1015.htm EX-10.15 52434
28 EX-10.16 d518298dex1016.htm EX-10.16 69786
29 EX-10.17 d518298dex1017.htm EX-10.17 275578
30 EX-10.18 d518298dex1018.htm EX-10.18 43979
31 EX-21.1 d518298dex211.htm EX-21.1 7642
32 EX-23.1 d518298dex231.htm EX-23.1 2319
33 EX-23.2 d518298dex232.htm EX-23.2 2221
34 EX-FILING FEES d518298dexfilingfees.htm EX-FILING FEES 27234
40 GRAPHIC g518298dsp01.jpg GRAPHIC 8407
41 GRAPHIC g518298dsp085.jpg GRAPHIC 84799
42 GRAPHIC g518298dsp086.jpg GRAPHIC 20489
43 GRAPHIC g518298dsp14a.jpg GRAPHIC 3807
44 GRAPHIC g518298dsp14b.jpg GRAPHIC 6033
45 GRAPHIC g518298dsp7.jpg GRAPHIC 7290
46 GRAPHIC g518298g01q73.jpg GRAPHIC 105390
47 GRAPHIC g518298g1220183454377.jpg GRAPHIC 2179
48 GRAPHIC g518298g1220183455639.jpg GRAPHIC 2221
49 GRAPHIC g518298g29e61.jpg GRAPHIC 667599
50 GRAPHIC g518298g81i79.jpg GRAPHIC 35007
51 GRAPHIC g518298g94u77.jpg GRAPHIC 102952
  Complete submission text file 0001193125-23-302158.txt   21270364

Data Files

Seq Description Document Type Size
35 XBRL TAXONOMY EXTENSION SCHEMA agle-20230930.xsd EX-101.SCH 104265
36 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agle-20230930_cal.xml EX-101.CAL 81848
37 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agle-20230930_def.xml EX-101.DEF 575882
38 XBRL TAXONOMY EXTENSION LABEL LINKBASE agle-20230930_lab.xml EX-101.LAB 785598
39 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agle-20230930_pre.xml EX-101.PRE 729274
159 EXTRACTED XBRL INSTANCE DOCUMENT d518298ds1_htm.xml XML 2401894
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-276251 | Film No.: 231510307
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)